← FDA Drug Approvals (Drugs@FDA)

NYSTATIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CROWN LABS INC · Approved 2017-09-26

Drug application

FDA Application #

ANDA207733

Application type

Abbreviated New Drug Application (Generic)

Brand name

NYSTATIN

Generic name

NYSTATIN CREAM

Active ingredients

NYSTATIN

Dosage form

CREAM

Route

TOPICAL

Marketing status

Prescription

Sponsor

CROWN LABS INC

Manufacturer

Crown Laboratories

First approval

2017-09-26

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown